NASDAQ:ELEV
Elevation Oncology, Inc.
- Stock
Last Close
3.61
17/05 20:00
Market Cap
117.06M
Beta: -
Volume Today
173.09K
Avg: 819.79K
PE Ratio
−2.16
PFCF: −1.98
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | ||||||
cash per share | 4.80 - | 12.06 151.11% | 3.88 67.82% | 2.44 37.15% | ||
company equity multiplier | -0.33 - | -3.51 975.60% | 1.06 130.31% | 1.92 80.74% | 1.63 15.36% | |
days of inventory outstanding | ||||||
days of payables outstanding | 4.75K - | |||||
days of sales outstanding | ||||||
dividend yield | ||||||
ebit per revenue | ||||||
ebt per ebit | 1.00 - | 1.00 0.04% | 1.01 0.56% | 1.13 12.63% | ||
effective tax rate | -0.00 - | -0.00 149.74% | ||||
enterprise value multiple | -6.36 - | 2.29 135.96% | -0.06 102.60% | 0.02 134.15% | ||
fixed asset turnover | ||||||
free cash flow per share | -0.75 - | -2.49 232.42% | -3.68 47.91% | -1.65 55.17% | ||
gross profit margin | ||||||
interest coverage | -197.39 - | -9.68 95.10% | ||||
inventory turnover | ||||||
long term debt to capitalization | 0.38 - | 0.35 5.42% | ||||
net income per ebt | 1 - | 1 0% | 1.00 0.03% | 1.00 0.04% | ||
net profit margin | ||||||
operating cash flow per share | -0.74 - | -2.49 234.34% | -3.67 47.76% | -1.65 55.13% | ||
operating profit margin | ||||||
payables turnover | 0.08 - | |||||
pretax profit margin | ||||||
price fair value | -8.20 - | 0.52 106.33% | 0.45 13.16% | 0.33 25.94% | ||
receivables turnover | ||||||
return on assets | -0.21 - | -0.21 0.43% | -1.01 371.15% | -0.51 49.20% | ||
return on capital employed | -0.23 - | -0.23 2.28% | -1.20 429.05% | -0.47 60.59% | ||
return on equity | 0.75 - | -0.23 130.44% | -1.94 751.56% | -0.83 57.00% | ||
total debt to capitalization | 0.38 - | 0.35 5.42% |
All numbers in USD (except ratios and percentages)